Farther Finance Advisors, LLC

Position in AMGN — Amgen Inc

CIK 1992825 SAN FRANCISCO, CA

Position in AMGN

as of Jun 30, 2026 · filed Jul 17, 2026 Compact

Position Value

$12,569,547

+$1,354,681 QoQ

Shares Held

34,711

+8.9% QoQ

Ownership

0.006%

of shares outstanding

% of Portfolio

0.30%

of 13F equity value

Holder Rank

#120

of 1,375 holders

Holding Since

Dec 2022

15 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

Farther Finance Advisors, LLC holds $187,005,351 across 18 Drug Manufacturers - General names. AMGN ranks #5 (6.7% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	LLY	ELI LILLY & Co	43,809	$52,545,833
2	JNJ	Johnson & Johnson	135,612	$34,441,379
3	ABBV	AbbVie Inc.	119,959	$30,186,482
4	MRK	Merck & Co., Inc.	120,685	$15,508,022
5	AMGN	Amgen Inc This page	34,711	$12,569,547
6	PFE	Pfizer Inc	395,297	$9,518,751
7	BMY	Bristol Myers Squibb Co	148,017	$8,528,739
8	GILD	Gilead Sciences, Inc.	58,478	$7,388,110

15 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$12,569,547	34,711	+8.9%	Shares	Sole	2026-07-17
2026-03-31	$11,214,866	31,874	+13.1%	Shares	Sole	2026-04-07
2025-12-31	$9,227,196	28,191	+65.5%	Shares	Sole	2026-01-23
2025-09-30	$4,807,277	17,035	+22.8%	Shares	Sole	2025-10-14
2025-06-30	$3,874,597	13,877	+8.4%	Shares	Sole	2025-07-11
2025-03-31	$3,988,151	12,801	+27.5%	Shares	Sole	2025-04-14
2024-12-31	$2,617,346	10,042	-7.6%	Shares	Sole	2025-02-10
2024-09-30	$3,502,422	10,870	+41.6%	Shares	Sole	2024-10-29
2024-06-30	$2,398,366	7,676	+58.1%	Shares	Sole	2024-07-31
2024-03-31	$1,380,657	4,856	+9.0%	Shares	Sole	2024-05-14
2023-12-31	$1,283,705	4,457	+63.0%	Shares	Sole	2024-02-15
2023-09-30	$735,058	2,735	+39.1%	Shares	Sole	2023-11-14
2023-06-30	$436,491	1,966	+74.3%	Shares	Sole	2024-05-14
2023-03-31	$272,694	1,128	+21.6%	Shares	Sole	2024-05-14
2022-12-31	$243,729	928	—	Shares	Sole	2023-09-12
No filing history on record for this holder in this stock.